D-0069-2022 Class III Terminated
FDA drug recall D-0069-2022 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Oct 12, 2021 and is designated Class III. Reason for recall: Failed Moisture Limits The recall status is terminated (terminated Aug 31, 2023). Affected quantity: 46,584 blister packs.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 3, 2021
- Initiation Date
- Oct 12, 2021
- Termination Date
- Aug 31, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 46,584 blister packs
Product description
AllerClear D-24 hr, (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10/240mg), 15-count blister packs, Manufactured by: Ohm Laboratories Inc., 1385 Livingston Avenue, North Brunswick, NJ 08902, NDC 63981-724-15
Reason for recall
Failed Moisture Limits
Distribution pattern
Nationwide within the United States
Code information
AC09723, Exo, Date 11/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0069-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026